Premaitha Health PLC | Ownership
Companies that own Premaitha Health PLC
Jarvis Investment Management Ltd.
27,187,000
7.03%
16,285,000
0.31%
08/02/2018
Investec Wealth & Investment Ltd.
20,510,000
5.3%
1,168,000
0.02%
08/02/2018
Hargreaves Lansdown Stockbrokers Ltd.
19,887,000
5.14%
3,806,000
0.02%
08/02/2018
Hargreave Hale Ltd.
12,152,385
3.14%
5,720
0.02%
09/18/2017
Harwood Capital LLP
11,000,000
2.84%
-6,000,000
0.22%
09/06/2018
Smith & Williamson Investment Management LLP
10,938,000
2.83%
0
0.02%
08/02/2018
ISPartners Investment Solutions AG
10,252,633
2.65%
-13,377,367
3.54%
05/17/2018
Walker Crips Stockbrokers Ltd.
9,895,000
2.56%
3,275,000
0.07%
08/02/2018
HSBC Bank Plc (Market-Maker)
9,717,000
2.5%
2,446,000
0.24%
08/02/2018
Hargreaves Lansdown Asset Management Ltd.
9,511,000
2.46%
837,000
0.02%
08/02/2018
| Address |
Rutherford House
Manchester Greater Manchester M15 6SZ
United Kingdom
|
|
Employees
|
- |
| Website |
http://premaitha.com/ |
| Updated |
09/14/2018 |
| Premaitha Health Plc engages in the manufacture, development and sale of molecular diagnostic products. Its product IONA test, which is marked as non-invasive in vitro diagnostic product for prenatal screening. The company was founded in 2013 and is headquartered in Manchester, the United Kingdom. |
